| PERIOD ENDING | 3-Oct-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 4,355,036 | 3,765,432 | 3,700,836 | 4,269,178 | | Cost of Revenue | 3,855,298 | 3,322,588 | 3,238,366 | 3,735,666 | | | Gross Profit | 499,738 | 442,844 | 462,470 | 533,512 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 392,666 | 301,754 | 406,997 | 393,420 | | Non Recurring | 18,072 | 161,624 |
-
| 1,348,845 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 89,000 | (20,534) | 55,473 | (1,208,753) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,917 | 10,892 | (8,364) | 817 | | Earnings Before Interest And Taxes | 91,917 | (9,642) | 47,109 | (1,207,936) | | Interest Expense | 15,282 | 14,578 | 17,608 | 17,435 | | Income Before Tax | 76,635 | (24,220) | 29,501 | (1,225,371) | | Income Tax Expense | 25,740 | 6,658 | 11,477 | (22,958) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 50,895 | (30,878) | 18,024 | (1,202,413) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 50,895 | (30,878) | 18,024 | (1,202,413) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $50,895 | ($30,878) | $18,024 | ($1,202,413) |
|
0.26% Nasdaq 0.00%
Income Statement
